Lobbying client
VIRON THERAPEUTICS
Development of novel therapies focused on the Membrane & Immuno-Technology' platform
Filings
4
Filed by
1
Reported in-house
—
Reported by firms
$200,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2022 to 2023
Filings
4 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination 1st Quarter 2023
|
BEN BARNES GROUP LP | $50,000 reported |
|
4th Quarter - Report 4th Quarter 2022
|
BEN BARNES GROUP LP | $75,000 reported |
|
3rd Quarter - Report 3rd Quarter 2022
|
BEN BARNES GROUP LP | $75,000 reported |
|
Registration 3rd Quarter 2022
|
BEN BARNES GROUP LP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| BEN BARNES GROUP LP | 3 | $200,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 4 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.